Related by context. All words. (Click for frequent words.) 79 Antitrust Approval 73 Antitrust Probe 72 Regulatory Clearance 69 Antitrust Case 69 Nasdaq Delisting Notice 69 Reverses Loss 68 Auto Parts Maker 68 Unsolicited Proposal From 68 Biotech Firm 68 EU# Million 68 Pending Acquisition 68 Reaffirms Outlook 68 Distribution Pact 68 Antitrust Complaint 68 Unsolicited Tender Offer 67 Stocks Pare Gains 67 Raises Bid 67 Approve Merger 67 Hostile Bid 67 #.#B Bid 67 Buyback Plan 67 Licensing Pact 67 Majority Stake 67 Terminate Merger Agreement 67 Controlling Stake 67 Asset Swap 67 Reaffirms FY# Outlook 67 Receives Marketing Authorization 67 Lowers Outlook 67 Sweetens Bid 67 Stock Buyback Plan 67 KB Home Swings 67 ots.CorporateNews 67 Plans Buyback 67 Takeover Speculation 67 Counteroffer 67 Amend Merger Agreement 67 Buyout Bid 67 Profit Misses Estimates 67 Unsolicited Proposal 67 ΞΕΝΗ ΔΗΜΟΣΙΕΥΣΗ ΑΝΑΚΟΙΝΩΣΗInfosys Finacle 66 Mulls Sale 66 Plans Job Cuts 66 Settle Litigation 66 Boosts Outlook 66 Raise Stake 66 Nasdaq Notice Regarding 66 Takeover Bids 66 Pct Stake 66 Buyout Proposal 66 Lifts Dividend 66 Lifts FY# Outlook 66 Ups Guidance 66 Antitrust Ruling 66 Cautious Outlook 66 Raises Forecast 66 Beats Views 66 Bln Deal 66 Cash Infusion 66 Beats Forecast 66 Nasdaq Delisting Notification 66 Antitrust Regulators 66 HSR Waiting Period 66 Q1 Profit Drops 66 Mln Euros 66 Withdraws Offer 66 Takeover Approach 66 EU#.# Billion [002] 66 Business Confidence Unexpectedly 66 Patent Lawsuit Against 66 Gets Clearance 66 Share Buyback 66 Shrs Rise 66 Beats Forecasts 66 Net Profit Soars 66 EUR#.# Billion [002] 66 Q1 Adj 66 Boosts Forecast 66 Nears Deal 66 Backs FY# View 66 Antitrust Settlement 66 Strengthens Position 66 Losses Narrow 66 Q4 Profit Plunges 66 Shares Soar 65 EU#.# Billion [003] 65 Advisers Urge 65 Boosts Buyback 65 EUR# Million 65 NASDAQ Deficiency Notice 65 Biometric Passports 65 Stock Plunges 65 EUR# Mln 65 Settle Patent Litigation 65 Narrows Losses 65 Lowers Guidance 65 Approves Merger 65 Dividend Quick Facts 65 Patent Lawsuit 65 Private Equity Buyout 65 Q1 Profit Dips 65 Backs FY# Outlook 65 Nasdaq Delisting 65 Ups Dividend 65 Rejects Takeover 65 Buyout Offer 65 Hikes Dividend 65 Posts 4Q 65 Board Unanimously Rejects 65 Contract Analyst Blog 65 #M Buyback [002] 65 Favorable Ruling 65 EU# Mln 65 Ink Pact 65 Extends Tender Offer 65 Q2 Adj 65 Profit Dips 65 TriCo Bancshares Announces 65 Patent Dispute 65 Debt Buyback 65 Trademark Infringement Lawsuit 65 Results Disappoint 65 Receives Clearance 65 Beats Expectations 65 Antitrust Regulator 65 Submits Proposal 65 EU# Billion 65 Raises Outlook 65 Seeks Buyer 65 Narrows Loss 65 Buyout Talks 65 4Q Profit Surges 65 1st Quarter Results 65 Equity Stake 65 Spy Swap 65 FTC Clears 64 Binding Offer 64 Restate Financials 64 Q3 Adj 64 Patent Ruling 64 Buying Spree 64 Patent Infringement Suit 64 Posts 1Q Profit 64 EU#.# Bln [002] 64 Shares Plummet 64 Profit Slips 64 Reaches Pact 64 Announces Job Cuts 64 Posts 3Q Profit 64 Final Approval 64 Withdraws Proposal 64 Q3 Profit Plunges 64 Electronic Passports 64 Shrs Up 64 Reaches Definitive Agreement 64 Ups Bid 64 Abandons Bid 64 Losses Widen 64 Announcement acc 64 Q4 Profit Climbs 64 Receives Subpoena 64 Positive Opinion 64 Q1 Profit Climbs 64 Q2 Profit Surges 64 Profit Triples 64 Shares Climb 64 Q3 Profit Surges 64 Guides FY# Earnings 64 Unsolicited Bid 64 Resolves Dispute 64 Expanded Indication 64 Profit Beats Expectations 64 Bribery Probe 64 Quarterly Profit Rises 64 Receives Notification 64 Purported Class 64 Q4 Adj 64 Terminate Agreement 64 Permanent Injunction Against 64 Patent Infringement Case 64 Q2 Profit Climbs 64 Merger Talks 64 Profit Leaps 64 Accounting Errors 64 Reaffirms FY# Guidance 64 Makes Headway 64 Billion Buyback 64 Posts Wider Loss 64 #.#B Buyout [003] 64 Share Buybacks 64 CFO Resigns 64 H.B. Fuller 64 Posts 4Q Loss 64 Closes Merger 64 Hat Trick Beverages HKBV 64 Explores Strategic Alternatives 64 Continues Climb 64 Hostile Offer 64 Less Than Estimated 64 Arthritis Drug 64 Billion Takeover 64 Vigorously Defend 64 Receives Unsolicited 64 Underperforms 64 Profit Exceeds Estimates 64 Slowing Growth 64 Posts 2Q Loss 64 FY# Guidance 64 Q2 Profit Soars 64 Stockholders Approve Merger 64 Completes Tender Offer 64 Postpones IPO 64 Acacia Subsidiary 64 Shareholder Opposes 64 Reconfirms 64 Profit Fell 64 Sees 2Q Profit 64 Posts 2Q Profit 64 Posts 4Q Profit 64 FY# Adj 64 Refile 64 3Q Profit Plunges 64 Receives Regulatory Approvals 64 Sell Majority Stake 63 Legal Dispute 63 Profit Sinks 63 #M Buyback [001] 63 Profit Grows 63 Revises FY# Outlook 63 Terminates Agreement 63 Goes Hostile 63 Undisclosed Amount 63 Nasdaq Deficiency Notice 63 Wider Loss 63 Deal Collapses 63 Second Quarter Profit Rises 63 Profit Slides 63 Slashes Jobs 63 Breakup Fee 63 Settles Dispute 63 Q2 Profit Drops 63 Confirms Receipt 63 EU#.# Billion [001] 63 Sees Profits 63 Infringement Case 63 Rosy Outlook 63 3rd Quarter Results 63 Regulator Approves 63 Gets Subpoena 63 Fourth Quarter Profit Drops 63 Informal Inquiry 63 Jumps Higher 63 Growth Slowed 63 Completes Buyout 63 Antitrust Lawsuit 63 EUR#.# Billion [003] 63 Begins Tender Offer 63 Antitrust Suit 63 Ups Stake 63 Regulatory Approvals 63 3Q Profit Rises 63 Receives Approvals 63 Stock Soars 63 Formalizes 63 Stock Tumbles 63 EUR#.# Billion [001] 63 Million Milestone Payment 63 Analyst Downgrade 63 Finalize Agreement 63 Approves Dividend 63 2Q Profit Down 63 Sweetened Offer 63 Tentative Approval 63 Submits Bid 63 1Q Profit Jumps 63 Profit Beats Estimates 63 Sees Slower Growth 63 Share Buyback Plan 63 Announces Share Buyback 63 Delist From 63 Sharply Higher 63 Milestone Payment From 63 Trims Outlook 63 Posts 1Q 63 Net Profit Drops 63 Submits Application 63 NASDAQ Listing Requirements 63 Tops Views 63 Resolve Dispute 63 Terminate Merger 63 Settle Probe 63 Receives Favorable Ruling 63 Bln Bid 63 Upward Momentum 63 Strengthens Presence 63 Growth Accelerates 63 Conflicting Signals 63 Granted Early Termination 63 Margin Expansion 63 Tariff Cuts 63 reaffirms FY# outlook 63 Regulatory Approval 63 Profits Drop 63 Stock Buyback 63 Announces Early Termination 63 Narrows 4Q Loss 63 Lowers Forecast 63 Consumer Confidence Improves 63 Doubles Capacity 63 Inks MOU 63 Interest Rate Increase 63 Annual Meeting Date 63 Q1 Profit Surges 63 Stocks Little Changed 63 Patent Infringement Lawsuit 63 Settle Patent Dispute 63 Profit Doubles 63 Receives Favorable 63 Cuts Forecast 63 3Q Profit Jumps 63 Makes Unsolicited Bid 63 Rejects Unsolicited 63 Q3 Profit Decreases 63 Third Quarter Profit Rises 63 Earnings Surge 63 Acquire Controlling Interest 63 Sweetens Offer 63 EUR1 Billion 63 Q1 Profit Plunges 63 Q3 Profit Jumps 63 Q1 Profit Soars 63 Boosts Share Buyback 63 Buyout Deal 63 Amid Slowdown 63 Expands Scope 63 Suspends Dividend 63 Takeover Talk 63 4Q Profit Slides 63 Spears Conservatorship 63 2nd Quarter Results 63 Interest Rate Increases 63 Boost Stake 63 Reduces Debt 63 News Unternehmensnachrichten DGAP Adhoc 63 Expands Capacity 63 Boosts Dividend 63 Increase Stake 63 Reduces Stake 63 Patent Suit Against 63 Neutral Analyst Blog 63 Matches Expectations 63 Share Buyback Program 63 Fiscal 1Q Profit 62 Satellite Radio Merger 62 Announce Expiration 62 Opens Probe Into 62 Clears Path 62 Outlook Disappoints 62 Swine Flu Vaccines 62 Expanding Presence 62 2Q Profit Drops 62 Expand Relationship 62 Patent Infringement Litigation 62 Profit Quadruples 62 Updates Guidance 62 Tops Forecasts 62 FY# Profit Surges 62 Boosts Profit 62 Awaits Approval 62 Shareholders Approve Proposed 62 Minority Stake 62 Settle Patent 62 BioElectronics Announces 62 Profit Soars 62 Profits Soar 62 Profit Growth Slows 62 Delayed Filing 62 Meets Expectations 62 Loss Narrowed 62 Takeover Attempt 62 Begins Shipment 62 Drug Maker 62 Mulling Bid 62 Apfn 62 Migraine Drug 62 Ups Ante 62 Buyout Speculation 62 Refinance Debt 62 Reports 2Q Profit 62 Exceeds Estimates 62 Secures Financing 62 NASDAQ Delisting Notice 62 Voluntary Withdrawal 62 Posts Narrower Loss 62 Planned Acquisition 62 Sell Itself 62 Holders Approve 62 1Q Profit Dips 62 2Q Pft 62 Mini Tender Offer 62 Billion Bid 62 4Q Profit Soars 62 Sees Wider 62 Settles Dispute With 62 Complies With 62 Posts Narrower 62 Completes Reorganization 62 Considers Sale 62 1Q Profit Down 62 Cap Hike 62 Successfully Completes Tender Offer 62 Inhaled Insulin 62 Competitive Position 62 Earnings Soar 62 Remains Neutral 62 Q2 Profit Plunges 62 Shareholder Suit 62 Announces Definitive Agreement 62 Boost Profits 62 Proxy Fight 62 Watchdog Fines 62 H1 Profit Declines 62 Provides Status 62 3Q Profit Falls 62 Q4 Profit Decreases 62 TiVo Posts Narrower 62 Profits Climb 62 Board Authorizes 62 Quarterly Profit Climbs 62 Merger Discussions 62 Profits Plunge 62 Receives Notice From 62 Profit Gains 62 Unanimous Approval 62 Q4 Profit Jumps 62 Dividend Hike 62 4Q Loss Widens 62 4Q Profit Drops 62 Settles Patent 62 Sign Definitive Agreement 62 Completes Purchase Of 62 Announce Early Termination 62 Q1 Profit Decreases 62 Percent Stake 62 Trims Loss 62 1Q Profit Surges 62 Nanophase Announces 62 OxyContin Maker 62 Hiring Spree 62 Settles Charges 62 Q3 Profit Drops 62 Ticks Higher 62 Arms Pact 62 Posts 2Q 62 Largest Shareholder 62 Rejects Takeover Bid 62 3Q Profits 62 Restate Results 62 Earnings Disappoint 62 Major Step Toward 62 Q1 Loss Narrows 62 Boosts Guidance 62 Stronger Warnings 62 Cuts Dividend 62 Strengthens Balance Sheet 62 Share Issuance 62 Device Maker 62 Pending Merger 62 Gets Approval 62 Wins Approval 62 Announces Intent 62 3Q Net Pft 62 Amends Merger Agreement 62 Proxy Proposals 62 Handset Makers 62 Achieves Significant 62 Diamyd Medical Diamyd 62 OKs Buyback 62 2Q Profit Soars 62 Accession Talks 62 Q1 Loss Widens 62 Abandons Plans 62 Exits Bankruptcy 62 Nearly Triples 62 Bleak Outlook 62 Stocks Erase Gains 62 Delays Filing 62 Quarterly Dividend Payment 62 Delta Reports Narrower 62 #M Stock Buyback 62 Announce Merger 62 Posts Hefty 62 Inflation Linked Bonds 62 Edges Higher 62 Inflation Rate Rises 62 Loss Shrinks 62 Quarterly Profit Drops 62 3Q Profit Surges 62 Genetically Modified Corn 62 XPEL Announces 62 Profits Tumble 62 Sees Profit 62 Anemia Drugs 62 Tainted Eggs 62 Restructures Debt 62 Interline Agreement 62 Regulatory Filing 62 Univest Corporation Declares 62 Buy Stake 62 Economy Shrinks 62 Schizophrenia Drug 62 Interest Rate Concern 62 Analyst Upgrade 62 Q4 Loss Narrows 62 Entire Stake 62 Posts Modest 62 Merger Approved 62 Obtains Financing 62 Forecast Raised 62 Backs FY# Guidance 62 Defends Itself 62 Unemployment Climbs 62 Demonstrates Commitment 62 Bigger Than Expected 62 Trade Deficit Widens 62 Upside Surprise 62 Output Declines 62 Shares Surge 61 Remains Committed 61 Reassure Investors 61 Shares Slump 61 License Pact 61 Reactor Shutdown 61 Reports 4Q Loss 61 Stocks Erase 61 Seeks Damages 61 Delisting Notice 61 Drops Sharply 61 Profits Dip 61 2Q Profit Falls 61 Ephedra Ban 61 Q4 Profit Drops 61 Generic Lovenox 61 Resume Trading 61 Merge Healthcare Announces 61 Slashes Outlook 61 Boosts Profits 61 Surpasses Expectations 61 4Q Profit Down 61 Budget Deficit Widens 61 Revenue Climbs 61 Announce Intention 61 Profit Tumbles 61 Profits Decline 61 Non Binding 61 Finalizes Sale Of 61 Announces Stockholder Approval 61 Trade Deficit Narrows 61 Debt Refinancing 61 Stake Sale 61 Suspends Quarterly Dividend 61 Patent Infringement Suit Against 61 Posts Slight 61 Infringement Suit 61 Exploring Strategic Alternatives 61 Surpasses Estimates 61 Milestone Payment 61 Makes Hostile 61 Profits Jump 61 Midday Trading 61 2Q Profit Slides 61 Shareholder Meeting Date 61 Acquire Stake 61 Takeover Rumors 61 Rheumatoid Arthritis Drug 61 Reports Narrower Loss 61 Misses Expectations 61 Endesa Bid 61 Extends Offer 61 4th Qtr Profit Rises 61 GBP#.# Billion [001] 61 Misonix Announces 61 Acquisition Proposal 61 Sweetened Bid 61 Q3 Profit Soars 61 Completes Restructuring 61 More Than Doubled 61 Tougher Stance 61 3Q Profit Down 61 #.#B Buyout [001] 61 NexMed Receives 61 Percent Jump 61 Completes Asset 61 Regarding Proposed Acquisition 61 Terminates Contract 61 Enters Negotiations 61 Tight Range 61 Profits Rise 61 Delists 61 Beating Views 61 Settle Dispute 61 Complete Merger 61 DR Horton Swings 61 Restate Earnings 61 Uncertainty Remains 61 Restructure Debt 61 Receives CE Marking 61 Consolidates Operations 61 FY# Profit Declines 61 EPS Tops Estimate 61 Profit Edges Up 61 Billion Buyout 61 Manufacturing Growth Slows 61 Gout Drug 61 Boosts Stake 61 Enters Into Definitive Agreement 61 Shareholder Vote 61 Demand Soars 61 Evaluate Strategic Alternatives 61 Announces Favorable 61 Increases Commitment 61 Dual Listing 61 Spy Case 61 Stock Plummets 61 Announces Intention 61 Trade Surplus Narrows 61 Multimillion Dollar Contract 61 Wage Freeze 61 Posts Smaller 61 Sweeping Changes 61 Q4 Profit Soars 61 For Undisclosed Terms 61 Ratings Unaffected 61 Ticker Symbol Change 61 Testosterone Patch 61 Fourth Quarter Profit Rises 61 Settles Patent Dispute 61 4th Qtr Loss 61 Weight Loss Drug 61 Epilepsy Drug 61 Creditor Protection 61 Drug Coated Stent 61 Mulls Bid 61 Debuts Next Generation 61 Be Bought 61 Lower Than Expected 61 Increases Buyback 61 1Q Profit Slips 61 WestLB Downgrades 61 Net Loss Narrows 61 Subsidiary Expands 61 Issues Shareholder 61 2Q Profit Surges 61 Finalizes Acquisition 61 EUR#.# Bln [002] 61 Hostile Takeover Bid 61 Revenues Decline 61 Majority Ownership 61 Misses Views 61 Patent Suit 61 Edges Up 61 3Q Profit Drops 61 Announces FDA Clearance 61 Balance Sheet Restructuring 61 Japanese Stocks Climb 61 Beat Expectations 61 Billion Share Buyback 61 Shareholder Lawsuit Against 61 Billion Update3 61 2Q Profit Up 61 2Q Profits 61 Stocks Advance Paced 61 Stereotaxis Announces 61 Slashes Price 61 Posts Wider 4Q Loss 61 Profit Slumps 61 Buyout Offers 61 REUTERS Christian Charisius 61 1Q Profit Drops 61 Provides Clarification 61 Makes Hostile Bid 61 Shrs Fall 61 Protherics PLC announces 61 Stocks Climb 61 Provides Update Regarding 61 Reports Narrower 61 Buy Majority Stake 61 1Q Profits 61 Explores Possible 61 PDUFA Date 61 4Q Profit Slips 61 Share Repurchases 61 Grounds Flights 61 Subsidy Cuts 61 Subsidiary Enters 61 Be Delisted From 61 Steel Tariffs 61 B.V. 61 Directors Unanimously Rejects 61 Wide Ranging 61 Review Strategic Alternatives 61 Implant Sciences Announces 61 GDP Shrinks 61 Stocks Erase Losses 61 Update# 61 Stocks Rise Paced 61 Buyout Firms 61 Osteoporosis Drug 61 Psoriasis Drug 61 3Q Profit Climbs 61 Unexpectedly Declined 61 NASDAQ Notice Regarding 61 Posts Gains 61 Anemia Drug 61 Shareholder Approval 61 Million Share Buyback 61 Profit Misses 61 Enters Definitive Agreement 61 Wins Patent Infringement 61 Gloomy Forecast 61 Profit Little Changed 61 Plant Closings 61 Earnings Decline 61 Announces Dismissal 60 Posts Loss 60 Unions Agree 60 Announce Shareholder Approval 60 Airwaves Auction 60 Takeover Talks 60 Jointly Offer 60 Posts Strong 60 GRAS Status 60 Acquires Remaining Interest 60 Quick Facts2 60 Mideast Truce 60 Signs Pact 60 Misses Forecast 60 Regulators Approve 60 Hits Speed Bump 60 iPhone Exclusivity 60 Shares Tumble 60 1Q Profit Soars 60 1Q Profit 60 Sharply Lower 60 NASDAQ Delisting 60 Regains Compliance 60 Extend Reach 60 Profit Plunges 60 Files Definitive Proxy 60 H1 Loss Narrows 60 Consumer Confidence Drops 60 Faces Delisting 60 Spins Off 60 Confirms Commitment 60 Mulls Options 60 Receives Complete Response 60 Business Confidence Improves 60 1Q Profit Up 60 4Q Profit Dips 60 Acquire Assets 60 Probe Update1 60 Trading Volumes 60 Gloomy Outlook 60 Settles Lawsuits 60 Nears Settlement 60 Tanker Contract 60 3Q Profit Soars 60 Projected Release Date 60 Temporarily Halts 60 3Q Profit Up 60 Debt Concern 60 Sees Possible 60 Urges Rejection 60 Textile Imports 60 FY# Loss Narrows 60 Amends Credit 60 1Q Profit Declines 60 Anti Spam Legislation 60 Injunction Against 60 Q3 Loss Narrows 60 Streamlines Operations 60 Patent Infringement Lawsuit Against 60 Q1 Profit Declines 60 Reaches Accord 60 Takeover Bid 60 Flight Disruptions 60 Bankruptcy Looms 60 1Q Loss Narrows 60 Seen Posting 60 Profits Surge 60 Explore Strategic Alternatives 60 Options Expensing 60 Patent Infringements 60 Cell Phone Makers 60 Extends Collaboration 60 Court Annuls 60 Provides Guidance 60 Broadens Scope 60 Resolve Dispute Over 60 Extend Relationship 60 Successfully Concludes 60 Spending Slows 60 First Patient Treated 60 Earnings Scorecard 60 Sells Stake 60 Resolutions Adopted 60 Announces Divestiture 60 Reports Wider Loss 60 Remains Unchanged 60 Consolidation Continues 60 Stock Buyback Program 60 At Slower Pace 60 Posts Profit 60 Sanctions Against 60 Previously Disclosed 60 Product Lineup 60 Acquire Controlling Stake 60 Damages Claim 60 Voluntarily Delist 60 Shareholders Approve Merger 60 Espionage Case 60 Emission Cuts 60 Premarket Movers 60 Boosts Productivity 60 Terminates Merger Agreement 60 Suit Vs 60 Achieves Record Sales 60 1Q Loss Widens 60 Repay Debt 60 Teva Pharma 60 Announces Licensing Agreement 60 Cancels Planned 60 Less Than Expected 60 Stocks Pare Losses 60 Fully Valued 60 Increases Capacity 60 Takes Stake 60 Smaller Than Expected 60 Larger Than Expected 60 GBP#.# Billion [002] 60 Expands Capabilities 60 Nasdaq Listing Requirements 60 Trademark Dispute 60 Stocks Rise Sharply 60 Licensing Deal 60 Q4 Profit Slips 60 Mukasey Nomination 60 Ekes Out 60 Announce Definitive Agreement 60 Lawsuit Involving 60 Stockholder Vote 60 Completes Sale Of 60 Reaches Deal 60 Buyout Rumors 60 Q2 Profit Decreases 60 Posts Fourth Quarter 60 More Than Quadruples 60 XM Sirius Merger 60 Q1 Profit Slips 60 Issues Clarification 60 Falls Sharply 60 Obtains Approval 60 FDA Panel Recommends 60 Industrial Output Drops 60 Firm Buys 60 Extends Deadline 60 Stockholders Approve Merger Agreement 60 1st Qtr Loss 60 1Q Profit Falls 60 Slashes Guidance 60 Update8 60 Chilly Reception 60 Reaches Tentative 60 Acquire Remaining 60 Trade Surplus Widens 60 Contract Renewal 60 Outlines Steps 60 Announcement Regarding 60 FY# Loss Widens 60 Tops Estimates 60 Shareholders Reject 60 Preliminary Injunction Against 60 #.#B Buyout [002] 60 Sirius XM Merger 60 Person Says Update1 60 PPD Declares 60 Talks Underway 60 Enhance Shareholder Value 60 Bln Euros 60 ISO Certifications 60 Shareholders Approve Acquisition 60 2Q Profit Slips 60 Makes Bid 60 Reaffirm Commitment 60 Sees Higher 60 Completes Divestiture 60 Formally Launches 60 Loss Widened 60 H1 Profit Rises 60 Deregister 60 Q3 Loss Widens 60 Enters Joint Venture 60 Stocks Sag 60 Defend Itself 60 Loses Momentum 60 Offices Raided 60 Significant Milestone 60 Rating Downgrade 60 Stocks Fall Sharply 60 Reverses Course 60 Terror Plot Suspects 60 Settles Litigation 60 Fast Track Status 60 STERIS Corporation Announces 60 NYSE Amex Listing 60 FDA Accepts 60 Few Surprises 60 Investigates Proposed Acquisition 60 Preliminary Approval 60 mcgeneral BUSINESS 60 Announces Definitive Merger 60 Ninth Consecutive 60 Issues Recall 60 Restate Financial 60 Regulator Fines 60 Reaches Profitability 60 #.#Bln 60 Amends Agreement 60 Bln Pounds 60 Offshore Drilling Ban 60 Drug Makers 60 Cholesterol Drug 60 2Q Profit Doubles 60 Fifth Consecutive 60 Slower Growth 60 Definitive Merger Agreement 60 Gerdau Ameristeel Announces 60 Sell Stake 60 Posts 3Q Loss 60 Contaminated Heparin 60 Gets Tentative 59 Buy Privately Held 59 Receives Delisting Notification 59 Sign Licensing Agreement 59 Loss Widens 59 Signs Merger Agreement 59 Flamel Technologies Announces 59 Seasonal Influenza Vaccine 59 Inflation Fears Ease 59 Meat Recall 59 Stays Neutral 59 2nd Qtr Profit 59 Unemployment Dips 59 Patent Spat 59 Restates Earnings 59 FY# Profit Rises 59 3Q Loss Widens 59 Undervalues 59 GBP# Million 59 Trading Halted 59 Postpones Annual Meeting 59 Delist 59 Beating Estimates 59 Confirms Talks 59 Trims Losses 59 Textile Quotas 59 Commercializes 59 Maximize Shareholder Value 59 Million Buyback 59 Solar Wafer 59 Drill Permits 59 Quarter Results 59 Posts 3Q 59 Blood Thinner 59 Remain Listed 59 Not Disclosed 59 Improve Energy Efficiency 59 Q4 Loss Widens 59 Revises Guidance 59 Receives Tentative Approval 59 Seek Shareholder Approval 59 Stocks Drop Paced 59 EU1 Billion 59 RTI Biologics Announces 59 Rally Loses Steam 59 Cervical Cancer Vaccine 59 Court Nixes 59 Patent Upheld 59 Temporarily Suspends 59 Cuts Stake 59 Announces Organizational Changes 59 Airport Body Scanners 59 Remains Bullish 59 Stocks Extend Losses 59 Patient Enrollment 59 Slightly Lower 59 Increases Size 59 Raises Full 59 Forecast Disappoints